Invention Grant
- Patent Title: Multispecific NK engager protein
-
Application No.: US16173114Application Date: 2018-10-29
-
Publication No.: US11267897B2Publication Date: 2022-03-08
- Inventor: Laurent Gauthier , Nadia Anceriz , Ariane Morel , Benjamin Rossi
- Applicant: INNATE PHARMA
- Applicant Address: FR Marseilles
- Assignee: INNATE PHARMA
- Current Assignee: INNATE PHARMA
- Current Assignee Address: FR Marseilles
- Agency: Baker, Donelson, Bearman, Caldwell & Berkowitz PC
- Agent Robin L. Teskin
- Main IPC: A61P43/00
- IPC: A61P43/00 ; C07K16/28 ; C12N15/62

Abstract:
Multispecific proteins that bind and specifically redirect NK cells to lyse a target cell of interest are provided without non-specific activation of NK cells in absence of target cells. The proteins have utility in the treatment of disease, notably cancer or infectious disease.
Public/Granted literature
- US20190048093A1 MULTISPECIFIC NK ENGAGER PROTEIN Public/Granted day:2019-02-14
Information query